PRENCIPE, Massimiliano
 Distribuzione geografica
Continente #
NA - Nord America 2.699
EU - Europa 611
AS - Asia 417
OC - Oceania 26
SA - Sud America 22
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.793
Nazione #
US - Stati Uniti d'America 2.685
SE - Svezia 200
SG - Singapore 164
IN - India 149
IT - Italia 131
CN - Cina 98
FI - Finlandia 94
UA - Ucraina 78
DE - Germania 27
AU - Australia 23
AR - Argentina 22
IE - Irlanda 22
GB - Regno Unito 17
CA - Canada 13
TG - Togo 11
BG - Bulgaria 10
DK - Danimarca 9
BE - Belgio 8
ZA - Sudafrica 6
IR - Iran 4
NL - Olanda 4
RO - Romania 4
CH - Svizzera 3
NZ - Nuova Zelanda 3
FR - Francia 2
AE - Emirati Arabi Uniti 1
CZ - Repubblica Ceca 1
EU - Europa 1
KR - Corea 1
MX - Messico 1
RU - Federazione Russa 1
Totale 3.793
Città #
Fairfield 398
Chandler 255
Ashburn 187
Woodbridge 180
Ann Arbor 154
Seattle 150
Houston 148
Cambridge 127
Wilmington 119
Singapore 105
Princeton 90
Plano 83
Dearborn 73
Boston 62
Beijing 55
San Paolo di Civitate 55
Lawrence 44
Rome 40
San Diego 37
Des Moines 36
Jacksonville 31
Sydney 23
Andover 22
Dublin 22
Federal 22
Boardman 21
Falls Church 18
Santa Clara 17
San Mateo 16
Millbury 15
Norwalk 13
Helsinki 12
Lomé 11
Toronto 11
Kunming 10
Sofia 10
New York 9
Brussels 8
Bühl 6
Jinan 6
Westminster 6
Hefei 4
Nanchang 4
Pune 4
Auckland 3
Buffalo 3
Frankfurt am Main 3
Hebei 3
Nanjing 3
Redmond 3
Salerno 3
San Jose 3
Shenyang 3
Silverton 3
Bremen 2
Dallas 2
Fremont 2
Guangzhou 2
Indiana 2
London 2
Mannheim 2
Milan 2
Muizenberg 2
Tappahannock 2
Vicenza 2
Auburn Hills 1
Baotou 1
Bern 1
Brno 1
Changsha 1
Chuxiong 1
Copenhagen 1
Dubai 1
Fasano 1
Fuzhou 1
Gangnam-gu 1
Genoa 1
Grafing 1
Groningen 1
Hangzhou 1
Imola 1
Johannesburg 1
Jönköping 1
Mexico City 1
Monmouth Junction 1
Montréal 1
Nashville 1
New Bedfont 1
Paris 1
Phoenix 1
Pietraperzia 1
Provo 1
Redwood City 1
San Casciano in Val di Pesa 1
Sandston 1
Shanghai 1
Shaoxing 1
Southend 1
Suceava 1
Wandsworth 1
Totale 2.806
Nome #
Case report of adult- onset Allgrove Syndrome 112
Differential diagnosis of endodontic-related inferior alveolar nerve paraesthesia with cone beam computed tomography: a case report 101
EEG/fMRI study of ictal and interictal epileptic activity: Methodological issues and future perspectives in clinical practice 90
Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy 88
Acute and chronic effects of ethanol on cortical excitability 87
Lack of association between genetic variants in the mannose-binding lectin 2 (MBL2) gene and HPV infection 86
A longitudinal electroencephalographic study in acute leukaemia. 86
Determinants of plasma levels of brain natriuretic peptide after acute ischemic stroke or TIA 83
Feasibility and Clinical Utility of Transesophageal Echocardiography in the Acute Phase of Cerebral Ischemia 77
Altered response to rTMS in patients with Alzheimer's disease 77
Intravenous Levetiracetam as first-line treatment of status epilepticus in the elderly 77
Ictal epileptic headache as "subtle" symptom in generalized idiopathic epilepsy 77
An emergency clinical pathway for stroke patients - results of a cluster randomised trial (Isrctn41456865). 75
BETA2-MICROGLOBULIN SERUM LEVEL IS NOT A MARKER OF DISEASE ACTIVITY IN MULTIPLE SCLEROSIS 74
Drug resistant ADLTE and recurrent partial status epilepticus with dysphasic features in a family with a novel LGI1 mutation: electroclinical, genetic, and EEG/fMRI findings 74
Diffusion-weighted magnetic resonance imaging in patients with partial status epilepticus 73
Effects of repetitive transcranial magnetic stimulation on spike-and-wave discharges 72
Specific therapies for ischaemic stroke: rTPA and others. 69
Use of levetiracetam in treating epilepsy associated with other medical conditions 68
Long-term prognosis after a minor stroke: 10-year mortality and major stroke recurrence rates in a hospital-based cohort. 68
Focal epileptic seizure induced by transient hypoglycaemia in insulin-treated diabetes. 67
Seizures in Alzheimer's disease: a retrospective study of a cohort of outpatients. 62
An observational study on electrolyte disorders in the acute phase of ischemic stroke and their prognostic value 61
Video-EEG study of psychogenic nonepileptic seizures: Differential characteristics in patients with and without epilepsy 60
Recurrent partial seizures with ictal yawning as atypical presentation of Hashimoto's encephalopathy (steroid-responsive encephalopathy associated with autoimmune thyroiditis) 60
Early clinical diagnosis of lacunar strokes. 59
Influence of the corticospinal tract on the cutaneous silent period: A study in patients with pyramidal syndrome 58
Venlafaxine and bladder function 58
Stroke, disability and dementia. Results of a population survey. 57
Transforming guidelines in routine practice. 57
Prevalence of dementia in an elderly rural population: Effects of age, sex, and education 56
The COX-2 G/C –765 polymorphism may modulate the occurrence of cerebrovascular ischemia 56
Electrical status epilepticus "invisible" to surface EEG in late-onset Rasmussen encephalitis 54
T cell response to amyloid-beta and to mitochondrial antigens in Alzheimer's disease 53
Circadian, circaseptan and circannual variations of the thrombolytic treatment in acute ischemic stroke. 52
Ictal hemodynmic changes in late-onset Rasmussen encephalitis 49
Long-term reproducibility of fMRI activation in epilepsy patients with Fixation Off Sensitivity. 49
Topiramate and cortical excitability in humans: A study with repetitive transcranial magnetic stimulation 49
Bladder and voiding dysfunction in Parkinson's disease 43
Autonomic cardiovascular function and baroreflex sensitivity in patients with cervical dystonia receiving treatment with botulinum toxin type A 43
Targeting stroke awareness public campaigns 42
Ventricular hemorrhage in Moya-moya disease. 39
Efficacy of acute ischemic stroke patients management in an emergency department stroke unit (EDSU). 39
Effetti tossici della profilassi per la meningosi leucemica: due casi di leucoencefalopatia. [Toxic effects of prophylaxis in meningeal leukemia: two cases of leukoencephalopathy (author's transl)]. 39
Is It necessary to revise the strict protocol for intravenous thrombolysis in acute icshemic stroke? Comparison between patients with and without some of the exclusion criteria. 38
Evolution and severity markers in 233 MS patients. 38
Suppressor cell activity and T-cell subsets in multiple sclerosis. 36
Baseline Total Cholesterol Levels and Risk of Symptomatic Hemorrhagic Transformation after Intravenous Thrombolysis in Acute Ischemic Stroke Patients 35
A longitudinal study in multiple sclerosis 35
Relationship of blood pressure and antihypertensive therapy with outcomes in acute ischemic stroke treated with intravenous thrombolysis: results from SITS-ISTR. 34
POST STROKE SLEEP APNEA: RESULTS OF A PILOT STUDY 34
Baseline Total cholesterol levels and risk of symptomatic hemorrhagic transformation after intravenous thrombolysis in acute ischemic stroke patients. 34
Metabolic alterations transients during paroxysmal activity in an epileptic patient with fixation-off sensitivity (FOS): a case study 34
Over-interpretation of electroclinical and neuroimaging findings in syncopes misdiagnosed as epileptic seizures 33
"Management of psychomotor agitation in hospitalized patients with dementia: the need for specific guidelines" 33
CLINICAL EXPERIENCE WITH LEVETIRACETAM IN IDIOPATHIC GENERALIZED EPILEPSY ACCORDING TO DIFFERENT SYNDROME SUBTYPES. 31
Predictors of outcome in severe acute stroke patients treated with intravenous thrombolysis. 31
Switching from branded to generic antiepileptic drugs as a confounding factor and unpredictable diagnostic pitfalls in epilepsy management 29
Prevalence and clinical significante of foetal origino f posterior cerebral arteries in stroke patients: a retrospective study. 29
Screening of microvascular endothelial cDNA library identifies rabaptin 5 as a novel autoantigen in Alzeimer’s disease. 29
Fattori prognostici in pazienti con sclerosi multipla di tipo recidivante-remittente. Studio longitudinale di 3 anni. 29
Clinical evolution after intravenous thrombolysis in acute ischemic stroke patients: early clinical improvement and early clinical deterioration. 26
Intravenous thrombolysis in acute ischemic stroke patients with previous anticoagulant therapy: clinical profiles and outcome. 25
Ictal haemodynamic changes in a patient affected by "subtle" Epilepsia Partialis Continua 25
Thrombolysis patients with NIHSS 0 at 24 hours: TIA or reverted stroke? 24
Symptomatic intracerebral haemorrhage, mortality and independence at 3 months for patients treated 3-4½ h after stroke onset in the sits thrombolysis register (SITS-ISTR). 24
Intravenous thrombolysis in acute ischemic stroke patients with previous anticoagulant therapy in Italy: clinica l profiles and outcome. 23
The SITS-MOST registry. 22
FATIGUE: CAN REHABILITATION TREARMENT HELP? 22
Frequency of intracranial vessel anomalies in cerebrovascular patients. 22
Status epilepticus in a patient with fragile X syndrome: electro-clinical features and peri-ictal neuroimaging. 22
Predictors of out come in severe acute stroke treated with intravenous thrombolysis in Italy. 21
COX-2 G/C-765 genotypes and the occurrence of cerebrovascular ischemia. An italian case-control study. 21
L'ictus ischemico: nuovi orientamenti clinici 20
Safe Implementation of Thrombolysis in Stroke- Monitoring Study (SITS-MOST) in Italy. 20
Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials. 18
Safe Implementation of Thrombolysis in Stroke - Monitoring Study (SITS-MOST) in Italy. 18
Tentative explanations for gender differences observed in ischemic stroke related atrial fibrillation. 17
Prevalence and priognostic significance of electrolyte imbalance at stroke onset. 15
Unusual clinical evolution after i.v. thrombolysis for vertebro-basilar stroke. 14
Impact of DW-MRI on ischemic stroke subtype classification. 14
Randomised clinical trial of an emergency system clinical pathway for the management of critical stroke patients in the Lazio Region (Italy). 14
Prevalence and prognostic significance of electrolyte imbalance at stroke onset. 10
Totale 3.875
Categoria #
all - tutte 10.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.431


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020685 0 0 9 32 81 142 123 90 81 56 48 23
2020/2021200 31 39 13 16 2 5 4 31 23 24 8 4
2021/2022864 1 59 93 30 105 26 13 81 70 70 145 171
2022/2023863 168 169 52 102 81 107 22 49 56 26 21 10
2023/2024310 23 55 13 27 16 33 8 18 1 35 44 37
2024/2025135 30 105 0 0 0 0 0 0 0 0 0 0
Totale 3.875